First AD

Second AD

OncLive Peer Exchange® 

® Peer Exchange video program comprises lively expert panel discussions feature peer-to-peer exchanges providing authoritative insights, opinions, and perspectives on important issues facing today’s health care professionals. Episodes focus on updates and insights across solid and hematologic malignancies, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecological cancers, and hematologic malignancies. 

Translating Evidence to Practice to Improve Outcomes in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Peer Exchange

Experts review some of the safety outcomes from the ZUMA-7 trial as well as discussing the clinical implications of the ZUMA-7 trial into their practice.

ZUMA-7: Clinical Implications

Front-Line Treatment Options for Patients with DLBCL

An Overview of R/R DLBCL

Treatment Options for Patients with R/R DLBCL

L-MIND: Review of Long-Term Analyses Data

Role of CAR T-cell Therapy in Patients with R/R DLBCL

Eligibility Criteria for CAR T-Cell Therapy in R/R DLBCL

Sequencing Therapies in Patients with R/R DLBCL

Potential Role of CAR T-cell Therapy in the Front-line Setting for Patients with R/R DLBCL

Future of R/R DLBCL